Massachusetts Financial Services’s iTeos Therapeutics ITOS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-23,662
| Closed | -$242K | – | 900 |
|
2024
Q3 | $242K | Buy |
+23,662
| New | +$242K | ﹤0.01% | 833 |
|
2024
Q2 | – | Sell |
-75,678
| Closed | -$1.03M | – | 878 |
|
2024
Q1 | $1.03M | Sell |
75,678
-168
| -0.2% | -$2.29K | ﹤0.01% | 783 |
|
2023
Q4 | $831K | Sell |
75,846
-2,397
| -3% | -$26.2K | ﹤0.01% | 781 |
|
2023
Q3 | $857K | Sell |
78,243
-2,998
| -4% | -$32.8K | ﹤0.01% | 776 |
|
2023
Q2 | $1.08M | Sell |
81,241
-1,913
| -2% | -$25.3K | ﹤0.01% | 747 |
|
2023
Q1 | $1.13M | Sell |
83,154
-40,708
| -33% | -$554K | ﹤0.01% | 746 |
|
2022
Q4 | $2.42M | Buy |
123,862
+2,622
| +2% | +$51.2K | ﹤0.01% | 704 |
|
2022
Q3 | $2.31M | Sell |
121,240
-1,106
| -0.9% | -$21.1K | ﹤0.01% | 705 |
|
2022
Q2 | $2.52M | Buy |
122,346
+70,959
| +138% | +$1.46M | ﹤0.01% | 697 |
|
2022
Q1 | $1.65M | Buy |
51,387
+26,558
| +107% | +$855K | ﹤0.01% | 769 |
|
2021
Q4 | $1.16M | Buy |
+24,829
| New | +$1.16M | ﹤0.01% | 810 |
|